Literature DB >> 25223780

Response to letters regarding article, "Anticoagulation and survival in pulmonary arterial hypertension: results from the Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension (COMPERA)".

Karen M Olsson1, Marion Delcroix2, H Ardeschir Ghofrani3, Henning Tiede3, Doerte Huscher4, Rudolf Speich5, Ekkehard Grünig6, Gerd Staehler7, Stephan Rosenkranz8, Michael Halank9, Matthias Held10, Tobias J Lange11, Juergen Behr12, Hans Klose13, Martin Claussen14, Ralf Ewert15, Christian F Opitz16, C Dario Vizza17, Laura Scelsi18, Anton Vonk-Noordegraaf19, Harald Kaemmerer20, J Simon R Gibbs21, Gerry Coghlan22, Joanna Pepke-Zaba23, Uwe Schulz24, Matthias Gorenflo25, David Pittrow26, Marius M Hoeper1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25223780     DOI： 10.1161/CIRCULATIONAHA.114.010921

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  3 in total

Review 1.  Pulmonary hypertension associated with antiphospholipid antibody: Call for a screening tool?

Authors:  Rukma Parthvi; Rutuja R Sikachi; Abhinav Agrawal; Ajay Adial; Abhinav Vulisha; Sameer Khanijo; Arunabh Talwar
Journal:  Intractable Rare Dis Res       Date:  2017-08

2.  Impact on survival of warfarin in patients with pulmonary arterial hypertension receiving subcutaneous treprostinil.

Authors:  Mona Ascha; Xuan Zhou; Youlan Rao; Omar A Minai; Adriano R Tonelli
Journal:  Cardiovasc Ther       Date:  2017-10       Impact factor: 3.023

Review 3.  Systemic Sclerosis-Associated Pulmonary Hypertension: Spectrum and Impact.

Authors:  Mario Naranjo; Paul M Hassoun
Journal:  Diagnostics (Basel)       Date:  2021-05-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.